Michael Shternfeld, MD
Otolaryngology · South Windsor, CTNPI 1649278714
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,432 of the $3,654 with a category attached, or 66.6%. 10 manufacturers reported payments, led by Acclarent, Inc at 51.5% of the total. Reporting peaked in 2024 at $1,731 and has fallen 63.0% since, to $641 in 2025.
Across 88 payments — averaging $41.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$2K
- Regeneron Healthcare Solutions, Inc.$662
- Optinose US, Inc.$564
- Sanofi$175
- Stryker$127
- Aerin Medical Inc.$123
- plus $121 from 4 others
What the payments were for
- Travel & lodging$1,21833%
- Food & beverage$2,43267%
- Gifts$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 18 | $1,881 |
| Regeneron Healthcare Solutions, Inc. | 26 | $662 |
| Optinose US, Inc. | 25 | $564 |
| Sanofi | 7 | $175 |
| Stryker | 4 | $127 |
| Aerin Medical Inc. | 3 | $123 |
| Neurent Medical Limited | 2 | $59 |
| Integra Lifesciences Corporation | 1 | $23 |
| Medtronic | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$137
- INSPIRA AIR Balloon Dilation System$119
How this compares
$3,654 in reported general payments places this provider in the 75th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine-FluticasoneAzelastine/Fluticasone | 13 | $2,085 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 13 | $1,372 |
| Ofloxacin | 14 | $264 |
| Montelukast Sodium | 36 | $261 |
| Methylprednisolone | 30 | $148 |
| Fluticasone Propionate | 14 | $130 |
| Doxycycline Hyclate | 15 | $104 |
| Mometasone Furoate | 21 | $96 |
| Prednisone | 15 | $79 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in South Windsor
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard StupakWestport$48K
- Belachew TessemaFarmington$45K
- Seth BrownFarmington$39K
- Howard BoeyNew Haven$19K
- Mahesh BhayaWaterbury$11K
- Neil SchiffWaterbury$10K
- Benjamin WycherlyFarmington$8K
- Dov BlochDanbury$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.